Siglec-7 was found to be significantly overexpressed on tumor-infiltrating CD8+ T cells within colon cancer tissues and ovarian cancer ascites, associated with the presence of exhaustion markers PD-1 and LAG-3. The gene discussed is CD8A; the disease is ovarian carcinoma.